Sarepta Therapeutics (SRPT) EPS (Weighted Average and Diluted) (QoQ) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 173.28% |
| Dec 31, 2025 | -686.00% |
| Sep 30, 2025 | -126.46% |
| Jun 30, 2025 | 141.09% |
| Mar 31, 2025 | -406.67% |
| Dec 31, 2024 | 341.18% |
| Sep 30, 2024 | 385.71% |
| Jun 30, 2024 | -81.08% |
| Mar 31, 2024 | -51.32% |
| Dec 31, 2023 | 265.22% |
| Sep 30, 2023 | -70.37% |
| Dec 31, 2022 | 57.82% |
| Sep 30, 2022 | -10.94% |
| Dec 31, 2021 | -138.33% |
| Sep 30, 2021 | 41.18% |
| Jun 30, 2018 | -203.64% |
| Jun 30, 2017 | -176.67% |
| Jun 30, 2016 | -3.05% |
| Sep 30, 2013 | -106.67% |
| Sep 30, 2012 | -720.00% |
| Jun 30, 2012 | 369.23% |
| Mar 31, 2012 | -750.00% |
| Dec 31, 2011 | 111.11% |
| Sep 30, 2011 | -400.00% |
| Jun 30, 2011 | 200.00% |
| Mar 31, 2011 | 234.75% |